Implications for sequencing of biologic therapy and choice of second anti‐TNF in patients with inflammatory bowel disease: results from the IMmunogenicity to Second Anti‐TNF therapy (IMSAT) therapeutic drug monitoring study. - Chanchlani, Neil; Lin, Simeng; Auth, Marcus K.; Lee, Chai Leng; Robbins, Helena; Looi, Shi; Murugesan, Senthil V.; Riley, Tom; Preston, Cathryn; Stephenson, Sophie; Cardozo, Wendy; Sonwalkar, Sunil A.; et al. (Alimentary Pharmacology & Therapeutics, 2022)